Press Releases

Press Releases

NAM Welcomes House Repeal of Onerous Medical Device Tax

Manufacturers Continue to Press Congress to Repeal All Harmful Obamacare Taxes

Washington, D.C. – National Association of Manufacturers (NAM) Vice President of Infrastructure, Innovation and Human Resources Policy Robyn Boerstling released the following statement on House passage of H.R. 184, the bipartisan Protect Medical Innovation Act:

Manufacturers welcome the House’s strong, bipartisan vote to repeal Obamacare’s tax on medical devices, and we call on the Senate to act swiftly, said Boerstling. During the two years this harmful tax was in effect, tens of thousands of manufacturing jobs disappeared, innovation stalled, and the cost of certain health care treatments requiring a medical device increased needlessly.

Manufacturers need certainty to negotiate affordable, best-in-class health plans for our employees, so we are also urging Congress to fully repeal other onerous Obamacare taxes, including the health insurance tax and the so-called ‘Cadillac tax.’ These priorities also have bipartisan support, and we urge Congress to provide manufacturers this additional relief.

On Monday, the NAM announced in a letter to members of the U.S. House of Representatives that it would key-vote passage of H.R. 184.


The National Association of Manufacturers (NAM) is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12 million men and women, contributes $2.25 trillion to the U.S. economy annually, has the largest economic impact of any major sector and accounts for more than three-quarters of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the Manufacturers or to follow us on Shopfloor, Twitter and Facebook, please visit

Contact us with questions or requests

[email protected]

View More